The 2025 OPEN MINDS Pitch Day—NeuroSigma
This presentation took place at The 2025 OPEN MINDS Strategy & Innovation Institute. Colin Kealey, President & Chief Executive Officer of NeuroSigma presented their product, The Monarch eTNS System, the first FDA-approved medical device for treating pediatric ADHD.
https://vimeo.com/1094141523?share=copy#t=0
https://soundcloud.com/user-202102826/neurosigma/s-FTNZrne2cpF?si=218048b0b10a40238460a8eda6e46398&utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing . . .